George P Luke

USPTO Granted Patents = 26 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 233(Granted Patents)

Company Filing History:

17 out of 125

Forma Therapeutics, Inc.

Novartis International Pharmaceutical, Ltd.

patents

5. 1 out of 88

Novo Nordisk Healthcare Ag

patents

6. 1 out of 134

Ligand Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

26 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12454532 - Inhibiting cyclic AMP-responsive element-binding protein (CREB) binding protein (CBP) (2025-10-28),

2. 12161634 - Pyruvate kinase R (PKR) activating compositions (2024-12-10),

3. 12053463 - Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile (2024-08-06),

4. 11795168 - Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) (2023-10-24),

5. 11723905 - Solid forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile (2023-08-15),

6. 11566013 - Inhibiting mutant isocitrate dehydrogenase 1 (mIDH1) (2023-01-31),

7. 11267805 - Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanone (2022-03-08),

8. 11111229 - Tetrahydroquinoline compositions as BET bromodomain inhibitors (2021-09-07),

9. 11084831 - Benzopiperazine compositions as BET bromodomain inhibitors (2021-08-10),

10. 10959994 - Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile (2021-03-30),

11. 10793554 - Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone (2020-10-06),

12. 10703764 - Benzopiperazine compositions as BET bromodomain inhibitors (2020-07-07),

13. 10611750 - Tetrahydroquinoline compositions as bet bromodomain inhibitors (2020-04-07),

14. 10532047 - Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile (2020-01-14),

15. 10377769 - Benzopiperazine compositions as BET bromodomain inhibitors (2019-08-13),

Title: The Innovative Journey of George P Luke

Introduction: George P Luke, a pioneering inventor hailing from Clinton, CT, is a remarkable woman who has made significant contributions to the field of technology and innovation.

Latest Patents: George P Luke's latest patents include cutting-edge advancements in renewable energy technology, sustainable agriculture solutions, and innovative healthcare devices.

Career Highlights: Throughout her illustrious career, George P Luke has been recognized for her groundbreaking inventions in the fields of clean energy, biotechnology, and artificial intelligence. Her work has revolutionized industries and improved the lives of countless individuals around the world.

Collaborations: George P Luke has collaborated with leading research institutions, universities, and multinational corporations to further develop and implement her innovative ideas. Her partnerships have led to the successful commercialization of several groundbreaking technologies.

Conclusion: George P Luke's passion for innovation, coupled with her relentless drive to push the boundaries of what is possible, has established her as a trailblazer in the world of invention. Her dedication to creating a more sustainable and technologically advanced future continues to inspire generations of inventors to come.

This text is generated by artificial intelligence and may not be accurate.